Thanks for subscribing!
Ymmunobio Accepted into Innosuisse Core Coaching
Ymmunobio Welcomes Dr. Kanda and Dr. Khairnar to Advisory Board
FDA Grants Orphan Drug Designation to Ymmunobio’s CEACAM Antibody for the Treatment of Liver Cancer
Drug Discovery & Development
Fierce Biotech: Appointment of Michel Janicot